Diabetes and the risk of osteonecrosis of the jaw

J Clin Endocrinol Metab. 2007 Mar;92(3):817-8. doi: 10.1210/jc.2007-0098.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use
  • Diabetes Complications
  • Diphosphonates / adverse effects*
  • Diphosphonates / therapeutic use
  • Humans
  • Jaw Diseases / chemically induced*
  • Neoplasms / complications
  • Neoplasms / drug therapy
  • Osteonecrosis / chemically induced*
  • Osteoporosis / complications
  • Osteoporosis / drug therapy
  • Risk Factors

Substances

  • Antineoplastic Agents
  • Bone Density Conservation Agents
  • Diphosphonates